People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Hoth Therapeutics, Inc. | — | Pharmaceuticals | Series A | $33.7M | $100.6M | 2019 |
| NXT Nutritionals Holdings, Inc. | — | Other | Series A | $8.7M | $85.8M | 2009 |
David Briones at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Briones on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Anthony Hayes | 1 | 7 |
| Wayne Linsley | 1 | 3 |
| Vadim Mats | 1 | 3 |
| Robb Knie | 1 | 2 |
| Ann McBrien | 1 | 2 |
| Jeff Pavell | 1 | 2 |
| Kenneth Rice | 1 | 2 |
| Mark Giresi | 1 | 2 |
| Stefanie Johns | 1 | 1 |
| David B. Sarnoff | 1 | 1 |
| David Sarnoff | 1 | 1 |
| Joshua Rosenbaum | 1 | 1 |
| Francis McCarthy | 1 | 1 |
| Richard Jordan | 1 | 1 |
| David Deno | 1 | 1 |
| Theodore Mandes, II | 1 | 1 |
| Paul Auerbach | 1 | 1 |
| Richard M. Jordan | 1 | 1 |
| Mark A. Giresi | 1 | 1 |
| Graig Springer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.